Decellularisation of matrices
    2.
    发明授权
    Decellularisation of matrices 有权
    基质去细胞化

    公开(公告)号:US07354749B2

    公开(公告)日:2008-04-08

    申请号:US10478198

    申请日:2002-05-20

    IPC分类号: C12N9/00 C12N9/48

    CPC分类号: A61L27/3687 A61L27/3633

    摘要: A method of preparing matrices or tissue engineered biomaterials for implantation, and in particular to a method of improving decellularisation of matrices or tissue engineered biomaterials prior to implantation. The method employs a single anionic detergent in combination with protease inhibitors.

    摘要翻译: 制备用于植入的基质或组织工程生物材料的方法,特别是在植入之前改进基质或组织工程化生物材料脱细胞化的方法。 该方法采用单一阴离子洗涤剂与蛋白酶抑制剂组合。

    Acellular vascular products
    3.
    发明授权
    Acellular vascular products 有权
    无细胞血管产品

    公开(公告)号:US09510933B2

    公开(公告)日:2016-12-06

    申请号:US13876429

    申请日:2011-09-26

    摘要: A product comprising a natural acellular xenogenic vascular tissue matrix having at least an 80% reduction in DNA content as compared to an untreated control vascular tissue matrix and being antigenically inert by being substantially free of epitopes capable of reacting with pre-formed human antibodies and also without having the ability to substantially activate complement. The invention also includes methods of preparing such products and uses of the products especially in bypass surgery.

    摘要翻译: 一种产品,其包含与未处理的对照血管组织基质相比具有至少80%的DNA含量降低的天然无细胞异种血管组织基质,并且通过基本上不含能够与预先形成的人抗体反应的抗原决定基因而具有抗原惰性 而不具有基本上激活补体的能力。 本发明还包括制备这些产品的方法和产品的用途,特别是在旁路手术中。